Literature DB >> 6233326

Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis.

T G Klingele, R M Burde.   

Abstract

Optic neuropathy developed in a patient with rheumatoid arthritis who had been receiving D-penicillamine for about 1 year. An associated finding included a 2+ positive antinuclear antibody test with a titer of 1:320. Optic disc swelling was resolved on high doses of intravenous steroids. The case resembles two previously reported cases of optic neuropathy which occurred in patients with Wilson's disease who were receiving penicillamine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233326     DOI: 10.3109/01658108409053863

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  2 in total

1.  Penicillamine treatment of Wilson's disease and optic neuropathy.

Authors:  A H Lee; N F Lawton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

2.  D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm.

Authors:  Yihui Goh; Benjamin Yong-Qiang Tan; Nicole Ya-Yuan Chong; Margaret Ma; Manjari Lahiri; Andrew Makmur; Yee Cheun Chan; Soon Boon Justin Wong; Joy Vijayan
Journal:  eNeurologicalSci       Date:  2021-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.